Mineralys Therapeutics (MLYS, $25.64) Moving Average Convergence Divergence (MACD) Histogram turned negative on August 14, 2026

#Biotechnology, #TechnicalAnalysis, #MACD, #Bearish, #Stocks, #MidCap, #Russel2000
MLYS - Mineralys Therapeutics
MACD signal
Bearish Trend
90%
Odds of DOWN Trend
Price: $25.64
Daily change: -$0.45 (-1.72%)
Daily volume: 387.6K
Capitalization: $2.3B
Industry: Biotechnology

This is a Bearish indicator signaling MLYS's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 41 similar cases where MLYS's MACD histogram became negative, and 37 of them led to successful outcomes. Odds of Success: 90%.